THE GLEBELAND SURGERY
THE GLEBE, BELBROUGHTON, STOURBRIDGECKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 101 | 117 | 86.3% | |
CKD 4 | 2008 | 120 | 138 | 87.0% | |
CKD 5 | 2009 | 54 | 67 | 80.6% | |
CKD 5 | 2010 | 23 | 25 | 92.0% | |
CKD 5 | 2011 | 27 | 33 | 81.8% | |
CKD 5 | 2012 | 31 | 37 | 83.8% | |
CKD 5 | 2013 | 32 | 39 | 82.1% | |
CKD003 | 2014 | 34 | 36 | 94.4% | |
CKD003 | 2015 | 32 | 36 | 88.9% | |
NM84 | 2016 | 27 | 35 | 77.1% | |
NM84 | 2017 | 21 | 28 | 75.0% | |
NM84 | 2018 | 21 | 30 | 70.0% | |
NM84 | 2019 | 6 | 10 | 60.0% | |
NM84 | 2020 | 7 | 12 | 58.3% | |
NM84 | 2022 | 3 | 7 | 42.9% |